在ALK3 (BMPR1A) 缺乏和自信号之间交叉,可以减轻骨质疏松症中的病理性骨损失
Zhixing Niu1, Yumeng Zhou2, Muchun Liang2
1State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Bone
|February 26, 2024
概括
骨形态遗传蛋白受体1A (BMPR1A) 在骨质疏松症中起着双重作用. 它的缺乏最初会减少骨质损失,但通过影响mTOR-自途径,会损害后来的骨质成熟.
科学领域:
- * 骨生物学和疾病
- * 分子和细胞生物学
- * 内分泌学 在内分泌学.
背景情况:
- * 绝经后骨质疏松症是一种主要的骨疾病,与骨形成受损有关.
- * 骨形态遗传蛋白 (BMP) 信号传递对骨质母细胞发育至关重要,但其在骨质疏松症中的作用尚不清楚.
- *BMPR1A是BMP信号通路中的一个关键受体.
研究的目的:
- * 调查BMPR1A在骨质疏松症中的病理作用.
- *阐明BMPR1A在骨质疏松性骨中的作用的基础分子机制.
- * 探索骨质疏松症的潜在治疗点.
主要方法:
- *使用Col1a1-creER小鼠模型在骨质母细胞中击倒BMPR1A.
- * 在体内分析了骨损失,矿物质粘附度和骨形成率.
- * 在体外研究了骨质前细胞增殖和矿物化.
- * 检查了mTOR-自途径的参与.
主要成果:
- * BMPR1A在骨质母细胞中降低了小鼠早期骨质疏松症相关的骨损失.
- *然而,BMPR1A缺乏导致骨晚期成熟的缺陷,减少矿物质粘附和骨形成率.
- *在体外,BMPR1A缺乏增加了骨质细胞前扩散,但在骨质疏松症条件下损害了矿化.
- *BMPR1A缺乏引发了mTOR-自途径的干扰,增强了短暂的增殖,但阻碍了最终的矿化.
结论:
- * BMPR1A 在骨质疏松性骨形成中充当双刃剑.
- * BMPR1A-mTOR/自轴在骨质疏松期间调节骨质母细胞功能方面具有重要作用.
- * 这项研究为开发骨质疏松症治疗策略提供了新的见解.
更多相关视频
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
13.2K
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.1K
相关概念视频
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
